BiotechHealthcareNews

The Cancer Research Collaboration Partners with Diabetes Prevention Program Provider Blue Mesa Health with California Residents in Mind Nasdaq:RDNT

NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) — The Cancer Research Collaboration (CRC), a non-profit group devoted to increasing the supply of cutting-edge most cancers analysis, in partnership with RadNet, Inc. (Nasdaq:RDNT), a nationwide market chief offering high-quality, cost-effective diagnostic imaging providers by a community of fully-owned and operated outpatient imaging facilities, are, as soon as once more, proud to work in conjunction with Blue Mesa Health’s (“Blue Mesa”) Transform diabetes prevention program.

Since 2016, Blue Mesa’s CDC-recognized diabetes prevention applications Transform and Transformemos have been serving to stem the tide of rising persistent disease-related health prices — a state of affairs the place roughly one-third of Americans is prediabetic. The applications are primarily based on the Centers for Disease Control and Prevention’s (CDC) landmark National Diabetes Prevention Program. Transform and Transformemos mix software program, house health monitoring through wi-fi scales, exercise trackers and distant health teaching to information contributors by a twelve-month life-style change program.

Since becoming a member of forces earlier this yr to ship this system to sufferers in New York, CRC, RadNet and Blue Mesa have determined to broaden their collaboration to California sufferers. Similar to NY, the Transform program might be offered to California CRC sufferers who’re in danger or are most cancers survivors and meet this system standards. The aim is for contributors to lose roughly 5-7% of their physique weight and add 150 minutes of reasonable bodily exercise over 52 weeks, which is correlated with a 58% discount in danger for kind 2 diabetes. These are necessary objectives for at-risk sufferers and breast most cancers survivors. Maintaining a healthy BMI can scale back the chance of growing breast most cancers and persistent circumstances comparable to kind 2 diabetes.

For extra details about the partnership or this system, go to: www.cancerresearchcollaboration.org/blue-mesa.

About Blue Mesa Health

Blue Mesa is a digital therapeutics firm with headquarters in New York, NY and Vancouver, BC. Blue Mesa supplies digital therapeutics applications in over 5 international locations and a number of other languages, with applications primarily based on the CDC’s National Diabetes Prevention Program. In the United States, employers, health plans, accountable care organizations, and hospital methods are recognizing the return on funding offered by culturally tailor-made and digitally delivered preventive health applications. Blue Mesa has raised funding from Nimbus Synergies Inc., Pallasite Ventures, Stanley Park Ventures Inc., and publicly traded know-how firm Mobio Technologies Inc. and different buyers. For extra data, go to www.bluemesahealth.com.

About the Cancer Research Collaboration

The Cancer Research Collaboration (CRC) is a non-profit group devoted to increasing the supply of cutting-edge most cancers analysis. CRC assists investigators, pharmaceutical firms, and CROs in figuring out new brokers and applied sciences for analysis and therapy of ailments.

CRC builds collaborations to foster innovation in analysis, training and supportive applications geared toward benefiting sufferers dwelling with most cancers or transferring past it. For extra data, go to www.cancerresearchcollaboration.org.

About RadNet, Inc.

RadNet, Inc. is the main nationwide supplier of freestanding, fixed-site diagnostic imaging providers in the United States primarily based on the variety of areas and annual imaging income. RadNet has a community of 341 owned and/or operated outpatient imaging facilities. In addition, RadNet supplies radiology data know-how options, teleradiology skilled providers and different associated services and products to prospects in the diagnostic imaging trade. For extra data, go to www.radnet.com.

CONTACT:          

Curtis Duggan, CEO and Co-Founder

1.347.468.3343

Source link

Show More

Related Articles

Trending Tickers

WISH
$9.18
27.72%
WISH
$9.18
27.72%
WISH
$9.18
27.72%
Back to top button